The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases
The inflammatory bowel diseases (IBDs) are lifelong chronic illnesses that place an immense burden on patients. The primary aim of therapy is to reduce disease burden and prevent relapse. However, the occurrence of relapses is often unpredictable. Current disease monitoring is primarily by way of cl...
Saved in:
Main Authors: | Bianca J. Galgut (Author), Daniel A. Lemberg (Author), Andrew S. Day (Author), Steven T. Leach (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammatory Bowel Disease in Children of Middle Eastern Descent
by: Christina Mai Ying Naidoo, et al.
Published: (2014) -
Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
by: Gilles Duvoisin, et al.
Published: (2017) -
Managing inflammatory bowel disease in adolescent patients
by: Bishop J, et al.
Published: (2014) -
Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
by: Andrew S. Day, et al.
Published: (2017) -
Value of fecal calprotectin in the diagnosis of chronic inflammatory bowel diseases in children
by: T.V. Yaroshevska, et al.
Published: (2018)